Oracle Health Sciences

Pharmaceutical companies could reduce the cost of drug development thanks to a new partnership that aims to scale the next generation of digital clinical trials. Read more


From AI to mHealth, Jim Streeter, global vice president life sciences product strategy Oracle Health Sciences give us his pharma predictions for next year. Read more


New research from Oracle Health Services in partnership with Informa Engage/Pharma Intelligence has revealed that more than 60% of drug safety experts are planning to use artificial intelligence (AI) to improve the speed and security Read more


A study of clinical trial professionals has revealed the top challenges and frustrations with current Randomization and Trial Supply Management/Interactive Response Technology (RTSM/IRT) systems as well as opportunities for improvement. Read more


Oracle Health Sciences has been identified as a leader in the top quartile position of the Everest Group PEAK Matrix Assessment of Life Sciences Clinical Trial Products 2017 — a fact-based analysis of global services providers, solutions and products Read more